Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015, Article ID 543541, 11 pages
http://dx.doi.org/10.1155/2015/543541
Research Article

Collagen Induced Arthritis in DBA/1J Mice Associates with Oxylipin Changes in Plasma

1Analytical BioSciences, LACDR, Leiden University, P.O. Box 9502, 2300 RA Leiden, Netherlands
2Sino-Dutch Centre for Preventive and Personalized Medicine, Leiden University, P.O. Box 9502, 2300 RA Leiden, Netherlands
3SU Biomedicine, Utrechtseweg 48, 3700 AJ Zeist, Netherlands
4Discovery Sciences, Janssen Research & Development, Turnhoutseweg 30, 2340 Beerse, Belgium
5TNO Innovation for Life, P.O. Box 360, 3700 AJ Zeist, Netherlands
6Tohoku Institute of Technology, Sendai 982-8577, Japan

Received 28 August 2015; Accepted 8 October 2015

Academic Editor: Nina Ivanovska

Copyright © 2015 Min He et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. H. S. Choy and G. S. Panayi, “Cytokine pathways and joint inflammation in rheumatoid arthritis,” The New England Journal of Medicine, vol. 344, no. 12, pp. 907–916, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. G. S. Firestein, “Evolving concepts of rheumatoid arthritis,” Nature, vol. 423, no. 6937, pp. 356–361, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Ferraccioli, L. Bracci-Laudiero, S. Alivernini, E. Gremese, B. Tolusso, and F. de Benedetti, “Interleukin-1β and interleukin-6 in arthritis animal models: roles in the early phase of transition from acute to chronic inflammation and relevance for human rheumatoid arthritis,” Molecular Medicine, vol. 16, no. 11-12, pp. 552–557, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. A. M. Connor, N. Mahomed, R. Gandhi, E. C. Keystone, and S. A. Berger, “TNFα modulates protein degradation pathways in rheumatoid arthritis synovial fibroblasts,” Arthritis Research and Therapy, vol. 14, no. 2, article R62, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Ottonello, M. Cutolo, G. Frumento et al., “Synovial fluid from patients with rheumatoid arthritis inhibits neutrophil apoptosis: role of adenosine and proinflammatory cytokines,” Rheumatology, vol. 41, no. 11, pp. 1249–1260, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. B. Bartok and G. S. Firestein, “Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis,” Immunological Reviews, vol. 233, no. 1, pp. 233–255, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Salmon, D. Scheel-Toellner, A. P. Huissoon et al., “Inhibition of T cell apoptosis in the rheumatoid synovium,” Journal of Clinical Investigation, vol. 99, no. 3, pp. 439–446, 1997. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Raza, D. Scheel-Toellner, C.-Y. Lee et al., “Synovial fluid leukocyte apoptosis is inhibited in patients with very early rheumatoid arthritis,” Arthritis Research and Therapy, vol. 8, no. 4, article R120, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Weinmann, R. A. Moura, J. R. Caetano-Lopes et al., “Delayed neutrophil apoptosis in very early rheumatoid arthritis patients is abrogated by methotrexate therapy,” Clinical and Experimental Rheumatology, vol. 25, no. 6, pp. 885–887, 2007. View at Google Scholar · View at Scopus
  10. L. Ottonello, G. Frumento, N. Arduino et al., “Delayed neutrophil apoptosis induced by synovial fluid in rheumatoid arthritis: role of cytokines, estrogens, and adenosine,” Annals of the New York Academy of Sciences, vol. 966, pp. 226–231, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. R. M. Pope, “Apoptosis as a therapeutic tool in rheumatoid arthritis,” Nature Reviews Immunology, vol. 2, no. 7, pp. 527–535, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Liu and R. M. Pope, “The role of apoptosis in rheumatoid arthritis,” Current Opinion in Pharmacology, vol. 3, no. 3, pp. 317–322, 2003. View at Publisher · View at Google Scholar
  13. D. A. Siwik and W. S. Colucci, “Regulation of matrix metalloproteinases by cytokines and reactive oxygen/nitrogen species in the myocardium,” Heart Failure Reviews, vol. 9, no. 1, pp. 43–51, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Ishiguro, T. Ito, K. Miyazaki, and H. Iwata, “Matrix metalloproteinases, tissue inhibitors of metalloproteinases, and glycosaminoglycans in synovial fluid from patients with rheumatoid arthritis,” The Journal of Rheumatology, vol. 26, no. 1, pp. 34–40, 1999. View at Google Scholar · View at Scopus
  15. A. E. Koch, M. V. Volin, J. M. Woods et al., “Regulation of angiogenesis by the C-X-C chemokines interleukin-8 and epithelial neutrophil activating peptide 78 in the rheumatoid joint,” Arthritis and Rheumatism, vol. 44, no. 1, pp. 31–40, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Kapoor, F. Kojima, and L. J. Crofford, “Arachidonic acid-derived eicosanoids in rheumatoid arthritis: implications and future targets,” Future Rheumatology, vol. 1, no. 3, pp. 323–330, 2006. View at Publisher · View at Google Scholar
  17. U. N. Das, “Interaction(s) between essential fatty acids, eicosanoids, cytokines, growth factors and free radicals: relevance to new therapeutic strategies in rheumatoid arthritis and other collagen vascular diseases,” Prostaglandins, Leukotrienes and Essential Fatty Acids, vol. 44, no. 4, pp. 201–210, 1991. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Ozkan, S. Yardým-Akaydýn, A. Sepici, E. Keskin, V. Sepici, and B. Simsek, “Oxidative status in rheumatoid arthritis,” Clinical Rheumatology, vol. 26, no. 1, pp. 64–68, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. E. A. Ostrakhovitch and I. B. Afanas'ev, “Oxidative stress in rheumatoid arthritis leukocytes: suppression by rutin and other antioxidants and chelators,” Biochemical Pharmacology, vol. 62, no. 6, pp. 743–746, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Jaswal, H. C. Mehta, A. K. Sood, and J. Kaur, “Antioxidant status in rheumatoid arthritis and role of antioxidant therapy,” Clinica Chimica Acta, vol. 338, no. 1-2, pp. 123–129, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. E. van Wijk, M. Kobayashi, R. van Wijk, and J. van der Greef, “Imaging of ultra-weak photon emission in a rheumatoid arthritis mouse model,” PLoS ONE, vol. 8, no. 12, Article ID e84579, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. G. C. Shearer, W. S. Harris, T. L. Pedersen, and J. W. Newman, “Detection of omega-3 oxylipins in human plasma and response to treatment with omega-3 acid ethyl esters,” Journal of Lipid Research, vol. 51, no. 8, pp. 2074–2081, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. E. R. Greene, S. Huang, C. N. Serhan, and D. Panigrahy, “Regulation of inflammation in cancer by eicosanoids,” Prostaglandins & Other Lipid Mediators, vol. 96, no. 1–4, pp. 27–36, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Kühn and V. B. O'Donnell, “Inflammation and immune regulation by 12/15-lipoxygenases,” Progress in Lipid Research, vol. 45, no. 4, pp. 334–356, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. M. H. Shishehbor, R. Zhang, H. Medina et al., “Systemic elevations of free radical oxidation products of arachidonic acid are associated with angiographic evidence of coronary artery disease,” Free Radical Biology and Medicine, vol. 41, no. 11, pp. 1678–1683, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. G. P. Pidgeon, J. Lysaght, S. Krishnamoorthy et al., “Lipoxygenase metabolism: roles in tumor progression and survival,” Cancer and Metastasis Reviews, vol. 26, no. 3-4, pp. 503–524, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. P. B. M. C. Derogis, F. P. Freitas, A. S. F. Marques et al., “The development of a specific and sensitive LC-MS-based method for the detection and quantification of hydroperoxy- and hydroxydocosahexaenoic acids as a tool for lipidomic analysis,” PLoS ONE, vol. 8, no. 10, Article ID e77561, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. C.-Y. J. Lee, S. H. Huang, A. M. Jenner, and B. Halliwell, “Measurement of F2-isoprostanes, hydroxyeicosatetraenoic products, and oxysterols from a single plasma sample,” Free Radical Biology and Medicine, vol. 44, no. 7, pp. 1314–1322, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. B. Halliwell and C. Y. J. Lee, “Using isoprostanes as biomarkers of oxidative stress: some rarely considered issues,” Antioxidants and Redox Signaling, vol. 13, no. 2, pp. 145–156, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Yoshino, E. Sasatomi, and M. Ohsawa, “Bacterial lipopolysaccharide acts as an adjuvant to induce autoimmune arthritis in mice,” Immunology, vol. 99, no. 4, pp. 607–614, 2000. View at Publisher · View at Google Scholar · View at Scopus
  31. K. Strassburg, A. M. L. Huijbrechts, K. A. Kortekaas et al., “Quantitative profiling of oxylipins through comprehensive LC-MS/MS analysis: application in cardiac surgery,” Analytical and Bioanalytical Chemistry, vol. 404, no. 5, pp. 1413–1426, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. F. M. van der Kloet, F. W. A. Tempels, N. Ismail et al., “Discovery of early-stage biomarkers for diabetic kidney disease using ms-based metabolomics (FinnDiane study),” Metabolomics, vol. 8, no. 1, pp. 109–119, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. F. M. Van Der Kloet, I. Bobeldijk, E. R. Verheij, and R. H. Jellema, “Analytical error reduction using single point calibration for accurate and precise metabolomic phenotyping,” Journal of Proteome Research, vol. 8, no. 11, pp. 5132–5141, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. R. A. van den Berg, H. C. J. Hoefsloot, J. A. Westerhuis, A. K. Smilde, and M. J. van der Werf, “Centering, scaling, and transformations: improving the biological information content of metabolomics data,” BMC Genomics, vol. 7, article 142, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. J. van der Greef, P. Stroobant, and R. van der Heijden, “The role of analytical sciences in medical systems biology,” Current Opinion in Chemical Biology, vol. 8, no. 5, pp. 559–565, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. J. Xia, I. V. Sinelnikov, B. Han, and D. S. Wishart, “MetaboAnalyst 3.0—making metabolomics more meaningful,” Nucleic Acids Research, vol. 43, no. 1, pp. W251–W257, 2015. View at Publisher · View at Google Scholar
  37. J. A. Westerhuis, H. C. J. Hoefsloot, S. Smit et al., “Assessment of PLSDA cross validation,” Metabolomics, vol. 4, no. 1, pp. 81–89, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. I.-G. Chong and C.-H. Jun, “Performance of some variable selection methods when multicollinearity is present,” Chemometrics and Intelligent Laboratory Systems, vol. 78, no. 1, pp. 103–112, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Cassotti and F. Grisoni, “Variable selection methods: an introduction,” in Molecular Descriptors, p. 10, 2012. View at Google Scholar
  40. R. Medzhitov, “Origin and physiological roles of inflammation,” Nature, vol. 454, no. 7203, pp. 428–435, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. E. Choy, “Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis,” Rheumatology, vol. 51, supplement 5, pp. v3–v11, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. C. A. Hitchon and H. S. El-Gabalawy, “Oxidation in rheumatoid arthritis,” Arthritis Research & Therapy, vol. 6, no. 6, pp. 265–278, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. R. E. Simmonds and B. M. Foxwell, “Signalling, inflammation and arthritis: NF-κB and its relevance to arthritis and inflammation,” Rheumatology, vol. 47, no. 5, pp. 584–590, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. J. Eguchi, T. Koshino, T. Takagi, T. Hayashi, and T. Saito, “NF-κB and I-κB overexpression in articular chondrocytes with progression of type II collagen-induced arthritis in DBA/1 mouse knees,” Clinical & Experimental Rheumatology, vol. 20, no. 5, pp. 647–652, 2002. View at Google Scholar · View at Scopus
  45. S. S. Makarov, “NF-kappa B in rheumatoid arthritis: a pivotal regulator of inflammation, hyperplasia, and tissue destruction,” Arthritis Research, vol. 3, no. 4, pp. 200–206, 2001. View at Publisher · View at Google Scholar · View at Scopus
  46. P. P. Tak and G. S. Firestein, “NF-κB: a key role in inflammatory diseases,” The Journal of Clinical Investigation, vol. 107, no. 1, pp. 7–11, 2001. View at Publisher · View at Google Scholar · View at Scopus
  47. N. Inazu, H. Kogo, and Y. Aizawa, “Effect of 13,14-dihydroprostaglandin F2alpha on steroid biosynthesis in rat ovary,” Japanese Journal of Pharmacology, vol. 31, no. 2, pp. 301–303, 1981. View at Publisher · View at Google Scholar · View at Scopus
  48. Y. Aizawa, N. Inazu, and H. Kogo, “Catabolism of prostaglandin F2α in rat ovary: differences between ovarian and uterine tissues,” Prostaglandins, vol. 20, no. 1, pp. 95–103, 1980. View at Publisher · View at Google Scholar · View at Scopus
  49. I. Ahnfelt-Rønne, E. Bramm, and E. Arrigoni-Martelli, “Chronic inflammation in adjuvant arthritic rats correlates with enhancement of 12-l-HETE-synthesis,” Agents and Actions, vol. 11, no. 6-7, pp. 587–589, 1981. View at Publisher · View at Google Scholar · View at Scopus
  50. P. Puri, M. M. Wiest, O. Cheung et al., “The plasma lipidomic signature of nonalcoholic steatohepatitis,” Hepatology, vol. 50, no. 6, pp. 1827–1838, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. X. Ding, J. Hu, J. Li et al., “Metabolomics analysis of collagen-induced arthritis in rats and interventional effects of oral tolerance,” Analytical Biochemistry, vol. 458, pp. 49–57, 2014. View at Publisher · View at Google Scholar · View at Scopus
  52. B. Liagre, P. Vergne, M. Rigaud, and J. L. Beneytout, “Expression of arachidonate platelet-type 12-lipoxygenase in human rheumatoid arthritis B synoviocytes,” FEBS Letters, vol. 414, no. 1, pp. 159–164, 1997. View at Publisher · View at Google Scholar · View at Scopus
  53. G. Kronke, J. Katzenbeisser, S. Uderhardt et al., “12/15-Lipoxygenase counteracts inflammation and tissue damage in arthritis,” The Journal of Immunology, vol. 183, no. 5, pp. 3383–3389, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. M. Kandouz, D. Nie, G. P. Pidgeon, S. Krishnamoorthy, K. R. Maddipati, and K. V. Honn, “Platelet-type 12-lipoxygenase activates NF-κB in prostate cancer cells,” Prostaglandins & Other Lipid Mediators, vol. 71, no. 3-4, pp. 189–204, 2003. View at Publisher · View at Google Scholar · View at Scopus
  55. B. C. Y. Wong, W. P. Wang, C. H. Cho et al., “12-Lipoxygenase inhibition induced apoptosis in human gastric cancer cells,” Carcinogenesis, vol. 22, no. 9, pp. 1349–1354, 2001. View at Publisher · View at Google Scholar
  56. C. Vonach, K. Viola, B. Giessrigl et al., “NF-κB mediates the 12(S)-HETE-induced endothelial to mesenchymal transition of lymphendothelial cells during the intravasation of breast carcinoma cells,” British Journal of Cancer, vol. 105, no. 2, pp. 263–271, 2011. View at Publisher · View at Google Scholar · View at Scopus
  57. L. M. Edwards, N. G. Lawler, S. B. Nikolic et al., “Metabolomics reveals increased isoleukotoxin diol (12,13-DHOME) in human plasma after acute intralipid infusion,” Journal of Lipid Research, vol. 53, no. 9, pp. 1979–1986, 2012. View at Publisher · View at Google Scholar · View at Scopus
  58. M. F. Sisemore, J. Zheng, J. C. Yang et al., “Cellular characterization of leukotoxin diol-induced mitochondrial dysfunction,” Archives of Biochemistry and Biophysics, vol. 392, no. 1, pp. 32–37, 2001. View at Publisher · View at Google Scholar · View at Scopus
  59. D. A. Thompson and B. D. Hammock, “Dihydroxyoctadecamonoenoate esters inhibit the neutrophil respiratory burst,” Journal of Biosciences, vol. 32, no. 2, pp. 279–291, 2007. View at Publisher · View at Google Scholar · View at Scopus
  60. M. Hayakawa, S. Sugiyama, T. Takamura et al., “Neutrophils biosynthesize leukotoxin, 9, 10-epoxy-12-octadecenoate,” Biochemical and Biophysical Research Communications, vol. 137, no. 1, pp. 424–430, 1986. View at Publisher · View at Google Scholar · View at Scopus
  61. R. A. Daynes and D. C. Jones, “Emerging roles of PPARs in inflammation and immunity,” Nature Reviews Immunology, vol. 2, no. 10, pp. 748–759, 2002. View at Publisher · View at Google Scholar · View at Scopus
  62. H. Duez, J.-C. Fruchart, and B. Staels, “PPARs in inflammation, atherosclerosis and thrombosis,” European Journal of Preventive Cardiology, vol. 8, no. 4, pp. 187–194, 2001. View at Publisher · View at Google Scholar · View at Scopus
  63. T. Itoh, L. Fairall, K. Amin et al., “Structural basis for the activation of PPARγ by oxidized fatty acids,” Nature Structural and Molecular Biology, vol. 15, no. 9, pp. 924–931, 2008. View at Publisher · View at Google Scholar · View at Scopus
  64. Z. Han, D. L. Boyle, A. M. Manning, and G. S. Firestein, “AP-1 and NF-kB regulation in rheumatoid arthritis and murine collagen-induced arthritis,” Autoimmunity, vol. 28, no. 4, pp. 197–208, 1998. View at Publisher · View at Google Scholar · View at Scopus
  65. F. Teng, “Modulation of inflammation, apoptosis, and oncogenesis by the nuclear transcription factor, NF-κB,” Chinese Dental Journal, vol. 25, no. 1, pp. 12–24, 2006. View at Google Scholar
  66. H. Okamoto, T. Iwamoto, S. Kotake, S. Momohara, H. Yamanaka, and N. Kamatani, “Inhibition of NK-κB signaling by fenofibrate, a peroxisome proliferator-activated receptor-α ligand, presents a therapeutic strategy for rheumatoid arthritis,” Clinical and Experimental Rheumatology, vol. 23, no. 3, pp. 323–330, 2005. View at Google Scholar · View at Scopus
  67. J. D. Ji, H. Cheon, J. B. Jun et al., “Effects of peroxisome proliferator-activated receptor-gamma (PPAR-gamma) on the expression of inflammatory cytokines and apoptosis induction in rheumatoid synovial fibroblasts and monocytes,” Journal of Autoimmunity, vol. 17, no. 3, pp. 215–221, 2001. View at Publisher · View at Google Scholar · View at Scopus
  68. Y. Kawahito, M. Kondo, Y. Tsubouchi et al., “15-Deoxy-delta(12,14)-PGJ(2) induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats,” The Journal of Clinical Investigation, vol. 106, no. 2, pp. 189–197, 2000. View at Google Scholar
  69. C. Jiang, A. T. Ting, and B. Seed, “PPAR-γ agonists inhibit production of monocyte inflammatory cytokines,” Nature, vol. 391, no. 6662, pp. 82–86, 1998. View at Publisher · View at Google Scholar · View at Scopus
  70. D. S. Straus and C. K. Glass, “Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms,” Trends in Immunology, vol. 28, no. 12, pp. 551–558, 2007. View at Publisher · View at Google Scholar · View at Scopus
  71. A. Hochreiter-Hufford and K. S. Ravichandran, “Clearing the dead: apoptotic cell sensing, recognition, engulfment, and digestion,” Cold Spring Harbor Perspectives in Biology, vol. 5, no. 1, 2013. View at Publisher · View at Google Scholar · View at Scopus
  72. L.-P. Erwig and P. M. Henson, “Clearance of apoptotic cells by phagocytes,” Cell Death and Differentiation, vol. 15, no. 2, pp. 243–250, 2008. View at Publisher · View at Google Scholar · View at Scopus
  73. O. Adam, C. Beringer, T. Kless et al., “Anti-inflammatory effects of a low arachidonic acid diet and fish oil in patients with rheumatoid arthritis,” Rheumatology International, vol. 23, no. 1, pp. 27–36, 2003. View at Google Scholar · View at Scopus
  74. C. Giaginis, A. Giagini, and S. Theocharis, “Peroxisome proliferator-activated receptor-γ (PPAR-γ) ligands as potential therapeutic agents to treat arthritis,” Pharmacological Research, vol. 60, no. 3, pp. 160–169, 2009. View at Publisher · View at Google Scholar · View at Scopus